Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2025-12-25 @ 9:46 PM
NCT ID: NCT00568451
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT00568451
Study Brief: Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
TMZ (Previously Treated) Previously chemotherapy treated cohorts: Temozolomide (TMZ) None None 0 2 1 2 View
TMZ (Chemo Naive) Chemotherapy-naive cohorts: Temozolomide (TMZ) None None 1 9 8 9 View
PC (Previously Treated) Previously chemotherapy treated cohorts: Paclitaxel and Carboplatin (PC) None None 0 0 0 0 View
PC (Chemo Naive) Chemotherapy-naive cohorts: Paclitaxel and Carboplatin (PC) None None 0 0 0 0 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 6 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 6 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 6 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 6 View
Leukopenia SYSTEMATIC_ASSESSMENT Investigations MedDRA 6 View
Lymphopenia SYSTEMATIC_ASSESSMENT Investigations MedDRA 6 View
Platelet count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 6 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 6 View
Bronchial infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 6 View
Neutropenia SYSTEMATIC_ASSESSMENT Investigations MedDRA 6 View